Evidence map›Paper›PMID 32700445›Full record

ArticleEMBO reports2020

PAX6D instructs neural retinal specification from human embryonic stem cell-derived neuroectoderm.

Yunlong Tao, Jingyuan Cao, Mingxing Li, Brianna Hoffmann, Ke Xu, Jing Chen, Xin Lu, Fangliang Guo, Xiang Li, M Joseph Phillips and 3 more

Abstract read
In one paragraph

Article in EMBO reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Chromatin Immunoprecipitation Assay in Mouse Retinal Tissue.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  4. Indian journal of ophthalmology · 2022
    Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yunlong Tao *Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0003-0377-7133
Jingyuan Cao *Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.
Mingxing LiDepartment of Rehabilitation of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Brianna HoffmannWaisman Center, University of Wisconsin-Madison, Madison, WI, USA.
Ke XuWaisman Center, University of Wisconsin-Madison, Madison, WI, USA.
Jing ChenDepartment of Rehabilitation of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xin LuWuhan No. 1 Hospital, Wuhan, China.
Fangliang GuoNeurological Department of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiang LiWaisman Center, University of Wisconsin-Madison, Madison, WI, USA.
M Joseph PhillipsWaisman Center, University of Wisconsin-Madison, Madison, WI, USA.
David M GammWaisman Center, University of Wisconsin-Madison, Madison, WI, USA.
Hong ChenDepartment of Rehabilitation of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.ORCID 0000-0002-8848-282X
Su-Chun ZhangWaisman Center, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0003-0563-5147

Funding

Summer Research ExperienceP50MH100031 · NIMH · UNIVERSITY OF WISCONSIN-MADISON · PI GOLDSMITH, HAROLD HILL · 2013 to 2017
$10.4M
Waisman Intellectual and Developmental Disabilities Research Center Down Syndrome RegistryU54HD090256 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI MESSING, ALBEE · 2016 to 2020
$6.0M
Reconstruction and Regulation of Neural Circuitry by Human NeuronsR01NS096282 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI ZHANG, SU-CHUN · 2017 to 2021
$1.7M
Transgenic Human Stem Cell Lines and ReagentsR24NS086604 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI ZHANG, SU-CHUN · 2014 to 2017
$1.1M
Special BD LSR FortessaS10OD018202 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI PATANKAR, MANISH S · 2014 to 2014
$351k
BD LSRFortessa 1S100OD018202-01Bleser Family FoundationBusta FoundationMinistry of Education of Singapore MOE2018T2-2-103NICHD NIH HHS U54 HD090256NIH HHS S10 OD018202NIMH NIH HHS P50 MH100031NINDS NIH HHS R01 NS096282NINDS NIH HHS R24 NS086604UW Foundation
6 · The paper itself

Abstract

PAX6 is essential for neural retina (NR) and forebrain development but how PAX6 instructs NR versus forebrain specification remains unknown. We found that the paired-less PAX6, PAX6D, is expressed in NR cells during human eye development and along human embryonic stem cell (hESC) specification to retinal cells. hESCs deficient for PAX6D failed to enter NR specification. Induced expression of PAX6D but not PAX6A in a PAX6-null background restored the NR specification capacity. ChIP-Seq, confirmed by functional assays, revealed a set of retinal genes and non-retinal neural genes that are potential targets of PAX6D, including WNT8B. Inhibition of WNTs or knocking down of WNT8B restored the NR specification capacity of neuroepithelia with PAX6D knockout, whereas activation of WNTs blocked NR specification even when PAX6D was induced. Thus, PAX6D specifies neuroepithelia to NR cells via the regulation of WNT8B.

Indexed as

Human Embryonic Stem CellsCell DifferentiationEye ProteinsHomeodomain ProteinsHumansNeural PlateRetinaWnt ProteinsEye ProteinsHomeodomain ProteinsWNT8B protein, humanWnt Proteinshuman pluripotent stem cellneuroepitheliaPAX6 isoformretinal progenitorWNT

Identifiers

PMID32700445
PMCPMC7507545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.